Track the Canadian Junior Mining Market at the speed of AI

Build a portfolio of Canadian junior mining companies on 6ix and get real-time updates the minute they announce something. Discover investor events, company profiles, and news in one place.

Please enable JavaScript to use all features of 6ix.com.

Originaltext

Diese Übersetzung bewerten

Mit deinem Feedback können wir Google Übersetzer weiter verbessern

Latest Press Releases

Time	Headline
9h ago	Delivery Hero confirms approach by Uber Technologies’ with respect to potential takeover offer
10h ago	Refers to Item 7 on the agenda: Report on the audit of the consolidated financial statements of Grupa Kęty SA
12h ago	The 4th BOCHK Science and Technology Innovation Prize Award Ceremony Concludes with Great Success
20h ago	Buffalo Potash Files Annual Information Form and New Technical Report
21h ago	Ionik Announces 30-Day Extension of Senior Debt Facility

About

0.58USD+0.00 +0.00%

Closed • Updated at 23:36 GMT+00:00

Market Cap$3.83M

Volume16.3K

Beta2.52

RSI45.35

Health TechnologyPharmaceuticals: Major

Galmed Pharmaceuticals Ltd. — investor relations, events, news, and company updates on 6ix.

Latest News

Galmed Announces Results from First-in-Man Pharmacokinetics Study of Oral Formulation of Aramchol Meglumine (AM); 400mg AM Increases Bioavailability by ~500% in Comparison to Aramchol Free Acid (AA) 300mg

Tissue Dynamics and Galmed Pharmaceuticals to Develop Human-Centered Chronic Cardiac Fibrosis Platform to Advance Aramchol-Based Therapeutics

Galmed Announces a Collaboration Agreement with Tel Aviv University to Evaluate its SCD1 inhibitor, Aramchol, as a Targeted Therapy for Metastatic Brain Cancers

Galmed Announces the Breakthrough Development of a Brain Penetrating New Formulation of its SCD1 inhibitor, Aramchol

Galmed Pharmaceuticals Ltd. Files Annual Report on Form 20-F for the Fiscal Year Ended December 31, 2025

Community Chat

Ask AI

Try asking